New theory could finally make quantum gravity a reality
Physicists have developed a novel approach to solving one of the most persistent problems in theoretical physics: uniting gravity with the quantum world.
In a recent paper published in the journal Reports on Progress in Physics, the scientists outline a reformulation of gravity that could lead to a fully quantum-compatible description — without invoking the extra dimensions or exotic features required by more speculative models, like string theory.
At the heart of the proposal is a rethinking of how gravity behaves at a fundamental level. While the electromagnetic, weak and strong forces are all described using quantum field theory — a mathematical framework that incorporates uncertainty and wave-particle duality — gravity remains the outlier. General relativity, Einstein's theory of gravity, is a purely classical theory that describes gravity as the warping of space-time geometry by mass and energy. But attempts to blend quantum theory with general relativity often run into fatal mathematical inconsistencies, such as infinite probabilities.
The new approach reinterprets the gravitational field in a way that mirrors the structure of known quantum field theories. "The key finding is that our theory provides a new approach to quantum gravity in a way that resembles the formulation of the other fundamental interactions of the Standard Model," study co-author Mikko Partanen, a physicist at Aalto University in Finland, told Live Science in an email.
Instead of curving space-time, gravity in their model is mediated by four interrelated fields, with each one similar to the field that governs electromagnetism. These fields respond to mass in much the same way that electric and magnetic fields respond to charge and current. They also interact with each other and with the fields of the Standard Model in a way that reproduces general relativity at the classical level while also allowing quantum effects to be consistently incorporated.
Related: 'Einstein's equations need to be refined': Tweaks to general relativity could finally explain what lies at the heart of a black hole
Because the new model mirrors the structure of well-established quantum theories, it sidesteps the mathematical problems that have historically hindered efforts to quantize general relativity. According to the authors, their framework produces a well-defined quantum theory that avoids common problems — such as unphysical infinities in observable quantities and negative probabilities for physical processes — that typically arise when general relativity is quantized using conventional, straightforward methods.
A key advantage of the approach is its simplicity. Unlike many models of quantum gravity that require undetected particles and additional forces, this theory sticks to familiar terrain.
"The main advantages or differences in comparison with many other quantum gravity theories are that our theory does not need extra dimensions that do not yet have direct experimental support," Jukka Tulkki, a professor at Aalto University and co-author of the paper, told Live Science in an email. "Furthermore, the theory does not need any free parameters beyond the known physical constants."
This means the theory can be tested without waiting for the discovery of new particles or revising existing physical laws. "Any future quantum gravity experiments can be directly used to test any (forthcoming) predictions of the theory," Tulkki added.
Despite the promising features, the model is still in its early stages. Although preliminary calculations indicate that the theory behaves well under the usual consistency checks, a complete proof of its consistency remains to be worked out.
Moreover, the framework has yet to be applied to some of the deepest questions in gravitational physics, such as the true nature of black hole singularities or the physics of the Big Bang. "The theory is not yet capable of addressing those major challenges, but it has potential to do so in the future," Partanen said.
Experimental verification may prove even more elusive. Gravity is the weakest of the known forces, and its quantum aspects are incredibly subtle. Direct tests of quantum gravity effects are beyond the reach of current instruments.
RELATED STORIES
—In a first, physicists spot elusive 'free-range' atoms — confirming a century-old theory about quantum mechanics
—Physicists create hottest Schrödinger's cat ever in quantum technology breakthrough
—Scientists claim to find 'first observational evidence supporting string theory,' which could finally reveal the nature of dark energy
"Testing quantum gravity effects is challenging due to the weakness of gravitational interaction," Tulkki said. Still, because the theory includes no adjustable parameters, any future experiment that probes quantum gravitational behavior could potentially confirm — or rule out — the new proposal.
"Given the current pace of theoretical and observational advancements, it could take a few decades to make the first experimental breakthroughs that give us direct evidence of quantum gravity effects," Partanen said. "Indirect evidence through advanced observations could be obtained earlier."
For now, Partanen and Tulkki's work opens up a fresh direction for theorists searching for a quantum theory of gravity — one that stays grounded in the successful frameworks of particle physics while potentially unlocking some of the most profound mysteries of the universe.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Gizmodo
an hour ago
- Gizmodo
This Bright Dot May Be an Entirely New Type of Space Object
At first, the dot looked like any other star. Then the astrophysicists switched to polarized light and found themselves looking at an entirely unexpected sight. 'Everything else disappeared, even the bright central black hole, and only this little dot remained,' Elena Shablovinskaia, an astrophysicist at Universidad Diego Portales in Chile and the Max Planck Institute for Radio Astronomy in Germany, told Gizmodo. Shablovinskaia's team believes they've discovered an entirely new kind of space object, which they've dubbed 'Punctum.' Like its name, Latin for 'point' or 'dot,' Punctum is a compact, bright splotch of light in space—but it's only visible at millimeter wavelengths and harbors an unusually organized magnetic field. A paper on Punctum has been accepted for publication in Astronomy & Astrophysics and is currently available on arXiv. The team wanted to show that Punctum is simply an unusual example of a known phenomenon, such as a magnetar or a supernova remnant. NGC 4945, where Punctum lives, is a nearby galaxy known for hosting an active population of baby stars—so it made sense to assume Punctum was one of them. After all, NGC 4945 resides so close to the Milky Way that astrophysicists thought they had a solid grasp of the galaxy. We couldn't have missed something 'hiding in plain sight,' as Shablovinskaia put it…could we? But the more they tried to force Punctum into established astrophysical wisdom, the more it seemed to defy it. For example, Punctum disappeared when the team checked the same region using X-ray or radio telescopes, appearing only in the millimeter spectrum with the Atacama Large Millimeter/submillimeter Array (ALMA). ALMA's ability to capture polarized light also revealed Punctum's weird magnetic field to the scientists, adding to its mystery. Astronomers Calculate Universe's Age With Atacama Desert Telescope 'So we compared its brightness, polarization, and spectrum to every extreme object we could think of—magnetars, pulsars, star-forming regions, and black hole jets,' Shablovinskaia recalled. 'Nothing matched.' But accepting that they'd struck something entirely new only raised more questions. What exactly is it? Where does Punctum—10,000 to 100,000 times brighter than magnetars and 10 to 100 times brighter than most supernovas—get its light? Could it be connected to a black hole or a neutron star? For Shablovinskaia, the best shot at finding the answer might be to investigate Punctum's strange polarization, 'basically a fingerprint of the magnetic environment,' she said. After all, the disturbingly neat alignment of the light waves around Punctum was what alerted the team to the object's weirdness. 'Usually, when light is produced in cosmic environments, it comes out mixed and disordered because the magnetic fields are tangled,' she explained. 'If we can measure [Punctum's magnetic field] at more wavelengths or watch how it changes over time, we can start to figure out what powers Punctum and whether it links to known astrophysical objects.' 'Punctum shows us the universe can still surprise us in places we thought we understood well,' Shablovinskaia said. 'For me, it's a reminder that astronomy is far from finished; we're still just beginning to discover the full variety of cosmic objects out there.' The new research marks another strong example of multi-messenger astronomy, in which astronomers use different kinds of signals to investigate a single source. Recently, astronomers found an ultramassive black hole using gravitational lensing. In this case, the scientists studied a specific behavior of light—polarization—alongside more conventional methods to double-check their results.
Yahoo
an hour ago
- Yahoo
ONWARD Medical Receives FDA IDE Approval to Initiate the Empower BP Pivotal Study with the ARC-IM System
THIS PRESS RELEASE CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE 7(1) OF THE EUROPEAN MARKET ABUSE REGULATION (596/2014) The investigational device exemption (IDE) allows initiation of a global pivotal study designed to assess the safety and efficacy of the ARCIM System®, an implantable neurostimulation technology developed to address blood pressure instability after spinal cord injury (SCI). Managing blood pressure instability is a major unmet need after SCI, with a significant impact on cardiovascular health and quality of life. Approximately 20 leading neurorehabilitation and neurosurgical research centers across the US, Canada and Europe are expected to participate. EINDHOVEN, The Netherlands, Aug. 18, 2025 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD and US ADR: ONWRY), the leading neurotechnology company pioneering therapies to restore movement, function, and independence in people with spinal cord injury and other movement disabilities, today announces that the US Food and Drug Administration (FDA) has approved an investigational device exemption for the ARC-IM System. With this approval, the Company can initiate the Empower BP pivotal study to assess the safety and efficacy of its implantable spinal stimulation system to address blood pressure instability after SCI. Empower BP is the Company's second global pivotal study, and the first to evaluate the implantable ARC-IM System. The randomized, double-blinded, sham-controlled study is expected to involve approximately 20 leading neurorehabilitation and neurosurgical research centers across the US, Canada and Europe, with first patient enrollment anticipated before the end of the year. The study will target participants with injuries at spinal cord levels C2-T6, injury severities of AIS A-D, and blood pressure instability characterized by chronic orthostatic hypotension (OH) and episodes of autonomic dysreflexia (AD). 'This is an important milestone for ONWARD and the SCI community,' said Dave Marver, CEO of ONWARD. 'Our ARC-IM System is designed to address several unmet needs, including blood pressure instability which is a major recovery target after spinal cord injury. With this IDE approval, we continue to advance our innovation pipeline and inspire realistic hope in restoring autonomic functions and independence after SCI and other movement disabilities.' Over 50% of people with SCI experience blood pressure instability, affecting nearly 350,000 people in the US and Europe.1 Blood pressure instability and persistent low blood pressure can threaten neurological recovery and negatively impact cardiovascular health and quality of life. The most frequent symptoms include dizziness, lightheadedness, blurred vision and fatigue.2 'Blood pressure instability, especially chronic low blood pressure, is one of the most hidden and unrecognized functional complications of spinal cord injury,' explains Dr. James Guest, neurosurgeon and Professor of Neurological Surgery at the University of Miami. 'It leaves people feeling unwell and can significantly impact their overall quality of life. Blood pressure instability also increases the risk of cardiovascular disease, making addressing this unmet need critical for improving the long-term outcomes of SCI.' The ONWARD ARC-IM System is an implanted neuromodulation platform designed to deliver targeted and personalized spinal cord stimulation. It is the first neuroprosthetic system designed to manage blood pressure instability in people with SCI. It comprises the implanted ONWARD Neurostimulator (IPG) and the ARC-IM Thoracic Lead. The ARC-IM Thoracic Lead is optimized for surgical placement in a specific region of the thoracic spinal cord, called the 'Hemodynamic Hotspot'. The location was first discovered by the Company's research partners at the Swiss Federal Institute of Technology Lausanne (EPFL), Centre Hospitalier Universitaire Vaudois (CHUV), and the University of Calgary in a study published in Nature in January 2021.3 In December 2022, the Company announced positive top-line interim clinical results from its feasibility studies showing improved blood pressure regulation and improved hemodynamic stability after SCI. In addition to immediate and sustained improved blood pressure levels, participants taking anti-hypotension drugs prior to the study significantly reduced or discontinued their medication. Participants also reported improved general well-being and a reduction in orthostatic hypotension, including reduced dizziness and increased energy. Detailed interim results from these studies are expected to be published later this year. Managing blood pressure instability is among the major unmet needs for which the FDA has awarded the Company one of its 10 Breakthrough Device Designations. This award is reserved for novel, cutting-edge therapies addressing unmet needs and provides potential regulatory and reimbursement benefits. To stay informed about ONWARD's research studies, technologies, and the availability of therapies in your area, please complete this webform. About ONWARD Medical ONWARD Medical is the leading neurotechnology company pioneering therapies to restore movement, function, and independence in people with spinal cord injuries, and other movement disabilities. Building on over a decade of scientific discovery, preclinical research, and clinical studies conducted at leading hospitals, rehabilitation clinics, and neuroscience laboratories, the Company developed ARC Therapy. It has subsequently been awarded 10 Breakthrough Device designations from the FDA. The Company's ARC-EX® System is cleared for commercial sale in the US. The Company is also developing an investigational implantable system called ARC-IM, which can be paired with a brain-computer interface (BCI) to restore thought-driven movement. Headquartered in the Netherlands, the Company has a Science and Engineering Center in Switzerland and a US office in Boston, Massachusetts. The Company is listed on Euronext Paris, Brussels, and Amsterdam (ticker: ONWD) and its US ADRs can be traded on OTCQX (ticker: ONWRY). For more information, please visit For Media Inquiries: Sébastien Cros, VP Communications media@ For Investor Inquiries: investors@ Notes and references: 1. Katzelnick CG et al. Blood Pressure Instability in Persons With SCI: Evidence From a 30-Day Home Monitoring Observation. Am J Hypertens. 2019 Sep 24;32(10):938-944 2. Carlozzi, N. E. et al. Impact of blood pressure dysregulation on health-related quality of life in persons with spinal cord injury: development of a conceptual model. Arch. Phys. Med. Rehabil. 94, 1721–1730 (2013) 3. Squair, J.W. et al. Neuroprosthetic baroreflex controls haemodynamics after spinal cord injury. Nature 590, 308–314 (2021) Forward-Looking Statements Certain statements, beliefs, and opinions in this press release are forward-looking, which reflect the Company's or, as appropriate, the Company directors' current expectations and projections about future events. By their nature, forward-looking statements involve several risks, uncertainties, and assumptions that could cause actual results or events to differ materially from those expressed or implied by the forward-looking statements. These risks, uncertainties, and assumptions could adversely affect the outcome and financial effects of the plans and events described herein. A multitude of factors including, but not limited to, delays in regulatory approvals, changes in demand, competition, and technology, can cause actual events, performance, or results to differ significantly from any anticipated development. Forward-looking statements contained in this press release regarding past trends or activities should not be taken as a representation that such trends or activities will continue in the future. As a result, the Company expressly disclaims any obligation or undertaking to release any update or revisions to any forward-looking statements in this press release as a result of any change in expectations or any change in events, conditions, assumptions, or circumstances on which these forward-looking statements are based. Neither the Company nor its advisers or representatives nor any of its subsidiary undertakings or any such person's officers or employees guarantees that the assumptions underlying such forward-looking statements are free from errors nor does either accept any responsibility for the future accuracy of the forward-looking statements contained in this press release or the actual occurrence of the forecasted developments. You should not place undue reliance on forward-looking statements, which speak only as of the date of this press release.


CBS News
3 hours ago
- CBS News
Former University of Michigan president picked for education role in United Kingdom
Former University of Michigan president Santa Ono has found a new role at the Ellison Institute of Technology's Oxford campus in the United Kingdom. The Ellison Institute of Technology announced Monday that Ono will be its new global president, working with others to develop and expand the school's science programs. The school focuses on topics such as health, medical science, sustainable agriculture, clean energy and artificial intelligence. "I look forward to collaborating with EIT's leadership teams worldwide to advance Larry Ellison's bold vision," Ono said in his statement. "I believe this innovative approach represents the most exciting investment in fundamental and applied research globally, and I am thrilled to be part of this collective effort to create solutions to humanity's most pressing challenges." Ono was named president of the University of Michigan in Ann Arbor in July 2022. At the time, he planned to stay for five years. This appointment came after the university's removal of former President Mark Schlissel, with Mary Sue Coleman serving as interim president. His career path took a twist when he announced his intention in May 2025 to become the president at the University of Florida. He was the sole finalist and earned approval from the school's board of trustees, pending approval from the Florida Board of Governors. That's when the bid stalled out. Ono's proposed contract included a number of stipulations and requirements, and some prominent conservatives raised questions about pro-Palestinian protests, climate change efforts and programs that focused on diversity, equity and inclusion at his former workplaces. The Florida Board of Governors then rejected his pending hire. The University of Michigan in the meantime said Ono would not be on its faculty and has begun the search process for its next president. Before taking the Michigan job, Ono was president and vice chancellor of University of British Columbia. He also had served as president at University of Cincinnati. His work in academic leadership spun out of his previous work in biomedical research and immunology. The above video originally aired June 20, 2025.